Alfred-Nobel-Str. 10
Monheim am Rhein 40789
Germany
49 2173 8955 4949
https://apontis-pharma.de
版塊: Healthcare
行業: Drug Manufacturers—Specialty & Generic
全職員工: 127
名稱 | 標題 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Mr. Karlheinz Gast | Chairman of the Management Board & CEO | 948.84k | 無 | 無 |
Mr. Thomas Milz | Chief Product Officer & Deputy Chairman of Management Board | 840.78k | 無 | 無 |
Mr. Thomas Zimmermann | Chief Financial Officer | 無 | 無 | 無 |
Mr. Harald Weyand | Head of Marketing | 無 | 無 | 無 |
Dr. Matthias Wendl | Head of Sales | 無 | 無 | 無 |
Ms. Susanne Böhm | Head of HR | 無 | 無 | 無 |
Dr. Olaf Randerath | Head of Medicine | 無 | 無 | 無 |
Dr. Susanne Endreß | Head of QA, Drug Safety & Regulatory Affairs | 無 | 無 | 無 |
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company is headquartered in Monheim am Rhein, Germany.
截至 無 止,Apontis Pharma AG 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。